Buy Lysergic acid methylamide (LAM) Cas 50485-06-8

Buy Lysergic acid methylamide (LAM) Cas 50485-06-8

Lysergic acid methylamide (LAM), also known as N-methyllysergamide (NM-LA), is a serotonin receptor modulator of the lysergamide family.^[1][2][4] It is the N–methyl derivative of ergine (lysergic acid amide; LSA) and the analogue of lysergic acid diethylamide (LSD) in which the N,N-diethyl groups have been replaced with one N-methyl group.^[1][2][4]

It is active in humans at a dose of approximately 500 μg and has roughly 20% of the potency of LSD as a drug.^[1][2][3] However, it has been said to produce autonomic effects but to produce no psychoactive or hallucinogenic effects at this dose.^[3][2][5] The drug has about 6.3% of the antiserotonergic potency of LSD in the isolated rat uterus in vitro.^[4][3][6][7]

LAM was first described in the scientific literature by Albert Hofmann and colleagues by 1955.^{[8][9][10][11]}